More on XAIR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-466.7% Growth)
- Ratings (8.8 Score)

Upcoming Events

- Earnings (6/17/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Beyond Air, Inc. (NQ:XAIR)
Delayed: 0.81 -0.02 (2.41%)
Prev. Close $0.83  
Open$0.84 
52 Wk High$ 
52 Wk Low$ 
Day High$0.84 
Day Low$0.79 
P/E N/A  
EPS$ 
Volume124,249 

Friends, Peers and Foes (?): XTLB (more...)

Feb 20, 2026 08:01 AM Beyond Air comments on review article about high-dose nitric oxide therapy
Feb 20, 2026 08:00 AM Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections
Feb 19, 2026 04:16 PM Beyond Air (XAIR) PT Lowered to $2 at Jones Trading
Feb 17, 2026 04:59 PM Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: Alyeska Investment Group, L.P.
Feb 17, 2026 06:48 AM Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Feb 14, 2026 01:39 PM Beyond Air, Inc. (XAIR) reported Q3 EPS ; Offers Guidance
Feb 13, 2026 04:16 PM Form 8-K Beyond Air, Inc. For: Feb 13
Feb 13, 2026 04:02 PM Form 10-Q Beyond Air, Inc. For: Dec 31
Feb 13, 2026 07:30 AM Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
Feb 10, 2026 09:01 AM Form 424B3 Beyond Air, Inc.
View All Articles

Entities mentioned with XAIR

View All Entities